NCT06529614
Recruiting
Not Applicable
A New Detection Method for MicroRNA in Patients With Breast Cancer
ConditionsBreast Cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Breast Cancer
- Sponsor
- Tongji Hospital
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Sensitivity and specificity of test
- Status
- Recruiting
- Last Updated
- 6 months ago
Overview
Brief Summary
We designed a new in-site detection method for MicroRNA in the serum of patients with breast cancer.
Investigators
Lei Dou
Dr.
Tongji Hospital
Eligibility Criteria
Inclusion Criteria
- •Healthy without serious diseases
Exclusion Criteria
- •situations that may affect the results
Outcomes
Primary Outcomes
Sensitivity and specificity of test
Time Frame: 8 months
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
on-invasive micro-RNA-based breast cancer diagnostics (Mammacheck)healthy subjectsC50.9Breast, unspecifiedDRKS00023108Prof. Dr. Thalia ErbesUniversitätsklinikum FreiburgKlinik für Frauenheilkunde2,004
Completed
Not Applicable
Circulating miRNAs.Breast CancerNewly Diagnosed Breast CancerRecurrent Breast CancerNCT01722851Cancer Trials Ireland255
Unknown
Not Applicable
Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated NeoplasiaBarrett's EsophagusGastroesophageal RefluxEsophageal AdenocarcinomaNCT02464930Midwest Biomedical Research Foundation220
Completed
Not Applicable
MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast CancerBreast CancerNCT01231386City of Hope Medical Center199
Unknown
Not Applicable
A Multicenter Breast Cancer Biospecimen RegistryBreast CancerNCT02712645Luminist, Inc.700